List View

By /

Clear

Displaying 2,751 - 2,775 of 2,995

Updates in relapsed/refractory Multiple Myeloma

Updates in relapsed/refractory Multiple Myeloma

Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

Acute Myeloid Leukemia

Acute Myeloid Leukemia

Myelodysplasia

Myelodysplasia

T-Cell NHL- Novel therapies

T-Cell NHL- Novel therapies

B-Cell NHL (Aggressive)-Relapsed (CAR T versus Bispecifics?)

B-Cell NHL (Aggressive)-Relapsed (CAR T versus Bispecifics?)

Lung Cancer Screening Programs: How do We ‘Take it to the Next Level’ to Improve Lung Cancer Outcomes?

Lung Cancer Screening Programs: How do We ‘Take it to the Next Level’ to Improve Lung Cancer Outcomes?

Existing and Emerging Tests for Cancer Interception: How Low do We have to Go (with the LOD)? Does Methylation Help?

Existing and Emerging Tests for Cancer Interception: How Low do We have to Go (with the LOD)? Does Methylation Help?

Incidental Pulmonary Nodule Programs (IPNs) – What are Best Practices for Monitoring and Diagnosing?

Incidental Pulmonary Nodule Programs (IPNs) – What are Best Practices for Monitoring and Diagnosing?

Assessing the Cancer Risk of Lung Nodules by Proteomic or Gene Expression Platforms

Assessing the Cancer Risk of Lung Nodules by Proteomic or Gene Expression Platforms

What is the Best Way to Assess Response to Therapy? Is Complete Pathologic Response the Best Surrogate?

What is the Best Way to Assess Response to Therapy? Is Complete Pathologic Response the Best Surrogate?

Perioperative Chemo/Immunotherapy and Surgical Outcomes

Perioperative Chemo/Immunotherapy and Surgical Outcomes

Debate- Is Perioperative Immunotherapy the New Standard of Care? Yes.

Debate- Is Perioperative Immunotherapy the New Standard of Care? Yes.

Debate- Is Perioperative Immunotherapy the New Standard of Care? No.

Debate- Is Perioperative Immunotherapy the New Standard of Care? No.

Which Patients Need Adjuvant Therapy?

Which Patients Need Adjuvant Therapy?

Update Progress in Targeted Therapies for Early-Stage NSCLC

Update Progress in Targeted Therapies for Early-Stage NSCLC

Assessing Resectability in Stage III NSCLC

Assessing Resectability in Stage III NSCLC

Combining Immunotherapy with Radiation for LA-NSCLC

Combining Immunotherapy with Radiation for LA-NSCLC

Moving the Bar Beyond PACIFIC. What is the Best Consolidation Therapy for People with Actionable and Non-Actionable Genes?

Moving the Bar Beyond PACIFIC. What is the Best Consolidation Therapy for People with Actionable and Non-Actionable Genes?

Progress in Biomarkers for SCLC – Are We Ready for Implementation into Routine Clinical Practice?

Progress in Biomarkers for SCLC – Are We Ready for Implementation into Routine Clinical Practice?

Treatment for SCLC in 2024: Where Are We At?

Treatment for SCLC in 2024: Where Are We At?

The Future of SCLC Treatment: Potential Agents and Where Are We Going?

The Future of SCLC Treatment: Potential Agents and Where Are We Going?

Role of Radiation Therapy in SCLC

Role of Radiation Therapy in SCLC

The Era of Antibody-Drug Conjugates (ADCs) and Bi-Specifics

The Era of Antibody-Drug Conjugates (ADCs) and Bi-Specifics

Resistance to KRAS Inhibitors

Resistance to KRAS Inhibitors